Recently, Wang and colleagues have performed in-vitro studies to show how the chemosensory signalling in the gut is altered in obesity: in fundic cultures of obese patients, glucose inhibited ghrelin secretion via TAS1R3 and bitter compounds, such as chloroquine, stimulated ghrelin secretion [84]. The gene discussed is GHRL; the disease is Obesity.